ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Krakoff moves To Scotland; Salmon Wins Waldenstrom Award; ONS endorses Reform

November 5, 1993

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003

ACS Goal To Raise Percentage Of Women Who Get Mammograms

July 31, 1992